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Identifying subjects with mild cognitive impairment (MCI) most likely to decline in cognition over time is a major focus in
Alzheimer’s disease (AD) research. Neuroimaging biomarkers that predict decline would have great potential for increasing the
efficacy of early intervention. In this study, we used high-resolution MRI, combined with a cortical unfolding technique to increase
visibility of the convoluted medial temporal lobe (MTL), to assess whether gray matter thickness in subjects with MCI correlated to
decline in cognition over two years. We found that thickness in the entorhinal (ERC) and subicular (Sub) cortices of MCI subjects at
initial assessment correlated to change in memory encoding over two years (ERC: r = 0.34; P = .003) and Sub (r = 0.26; P = .011)
but not delayed recall performance. Our findings suggest that aspects of memory performance may be differentially affected in the
early stages of AD. Given the MTL’s involvement in early stages of neurodegeneration in AD, clarifying the relationship of these
brain regions and the link to resultant cognitive decline is critical in understanding disease progression.
1. Introduction
Identifying optimal markers for subsequent cognitive decline
has become a major focus in Alzheimer’s disease (AD)
research, especially using neuroimaging tools. Advances in
neuroimaging research have led to a shift in focus from
using imaging for diagnosis of AD, to the current focus of
predicting conversion from preclinical states to AD. Recent
results suggest subjects with mild cognitive impairment
(MCI) convert to AD at an annual rate of 17% [1], although
other studies have reported conversion rates in the range
of 10–15% [2]. Classic MCI symptoms include deficits in
the memory domain greater than expected for age, while
maintaining normal overall cognition and daily functioning
[2]. Amnestic MCI in particular has been identified as a
precursor to AD [3]. However, predicting who among a
group of MCI patients is most likely to decline in cognition
within a specified period of time is more challenging.
Neuroimaging biomarkers that predict likelihood of decline
on an individual basis would have the greatest potential
benefit for assessing risk level in single patients before
the onset of the disease, including earlier therapeutic and
pharmacologic intervention (and, thus, increased treatment
efficacy), patient counseling, and the design of clinical
trials. Developing tools to detect progression and predict
conversion from MCI to AD is therefore a critical research
focus.
Neuroimaging biomarkers for predicting cognitive
decline or conversion to AD include [18F]fluorodeoxy-
glucose uptake (FDG-PET) in parietal, posterior cingulate,
and temporal brain regions [4, 5] and MRI evidence of
medial temporal lobe and hippocampal atrophy [6–9]. In
a comparison study that examined the ability of a number
of biomarkers to predict decline in a single participant
pool, FDG-PET significantly predicted conversion to AD
while hippocampal volume demonstrated a trend towards
significance in predicting decline but did not pass threshold
(P = .06) [1]. In a longitudinal study of MCI subjects
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assessed with (11)C-PIB as an in vivo marker of brain
amyloid load, PIB-positive subjects were more likely to
convert to AD than PIB-negative subjects [10].
Historically results on whether medial temporal lobe
(MTL) atrophy predicts conversion to AD have been mixed.
Some studies have shown a relationship between smaller
hippocampi and conversion from MCI to AD [6, 11, 12],
while others have not [13–16]. Previous results from our lab
in preclinical subjects [17] and findings from AD patients
[18] indicate that measuring gray matter thickness is a more
sensitive indicator of subtle structural changes related to AD
than traditional volumetric methods that assess total size
of a region. We suggest that increases in sensitivity among
neuroimaging tools may demonstrate a clearer picture of AD
pathology in its earliest stages.
Recent advances in resolution and image analysis tech-
niques enable us to investigate regional brain characteristics
previously beyond the scope of in vivo imaging. Our
approach examines subregions of the MTL system using
high-resolution MRI combined with cortical unfolding to
increase visualization of the convoluted MTL and directly
assess 3-dimensional anatomical integrity. Originally applied
to the visual cortex [19], we have adapted this technique to
the MTL structures including hippocampal subfields, ento-
and perirhinal cortices, subiculum, and parahippocampal
and fusiform gyri [17, 20–23]. Previous results from our
lab using this approach revealed reduced cortical thickness
in cognitively intact carriers of the APOE-4 variant [17]. In
the current study, we hypothesized that this technique would
detect a relationship between subtle structural differences
and cognitive decline in MCI subjects specific to cognitive
domains affected by neural loss in the MTL.
It is wellaccepted that the MTL plays an essential role in
associative memory [24]; however, the exact contribution of
subregional areas to different aspects of memory formation
is still under debate. It is clear that the pathological processes
of AD, which begin in the entorhinal cortex (ERC) before
spreading to hippocampus proper and other neocortical
regions, affect the formation of new memories early in
disease development. Pathologically, H. Braak and E. Braak
demonstrated in post mortem brains that the hallmark
neurofibrillary tangles evident in AD appear first in the
prealpha transentorhinal neurons and then spread to the
ERC proper [25]. From here, the tangles spread to the
subiculum (Sub) and Cornu Ammonis (CA) 1, then to CA
2 and 3 [26]. It is likely, therefore, that neuronal death in
ERC and potentially Sub and CA1 areas would be sensitive
predictors of subsequent decline in memory encoding.
While it is clear that an intact MTL is necessary for the
formation of episodic memory [27], it is still unclear how
specific subregions are involved in declarative learning [24].
A recent study of AD patients by Wolk and Dickerson aimed
to determine the whole-brain neural correlates of different
stages of episodic memory formation and their modula-
tion in Alzhiemer’s disease [28]. The authors focused on
whole-brain neural networks supporting cognitive domains
and found that volumetric analysis of the hippocampus
correlated with both immediate recall and delayed recall
performance. We suggest that further parcelation of the MTL
into substructures may help to more fully understand the
contribution of separate regions within the MTL to aspects
of memory performance in AD.
In the current study, we examined the relationship
between MTL subregions in amnestic MCI subjects and cog-
nitive performance two years later in key functional domains
using high-resolution imaging combined with a cortical
flattening algorithm applied to the MTL. We examined
specific functional domains separately by combining data
across several tests measuring similar cognitive functions,
thereby adding power and decreasing error variance. These
domains included executive functioning, processing speed,
memory encoding, and delayed memory. MTL subregions
are intimately tied to memory performance; specifically the
entorhinal cortex is known as the gateway of the hippocam-
pus [29], connecting the neocortex to the hippocampal
formation, and is heavily involved in the encoding of new
memories. We hypothesized, therefore, that thinner entorhi-
nal cortex in MCI patients at their initial visit would correlate
to greater cognitive decline in the encoding domain two years
later. To test this hypothesis, we correlated thickness metrics
in subregional areas of the MTL to memory performance
in the encoding domain. To the best of our knowledge,
this is the first study to assess anatomical integrity within
MTL subregions in MCI subjects and the correlation to
performance in encoding new associations at a two-year
follow-up.
2. Methods
2.1. Subjects. Participants were drawn from a pool of poten-
tial subjects (age range: 45 to 84 years) recruited through
local advertising of a study of mild memory impairment,
media coverage of the study, and referrals by physicians
and families for investigations intended to examine brain
structure and function using neuroimaging techniques in
cognitively healthy people, subjects with MCI, and AD,
from 2004 to 2008. Subjects with a history of psychiatric
or neurologic disorder, alcohol or substance abuse, head
trauma or other major systemic disease that affects brain
function, as well as hypertension and cardiovascular disease
were excluded. At both their initial and follow-up visits, all
subjects underwent diagnostic evaluation including physical
and medical examination, laboratory screening blood tests
that ruled out medical conditions possibly affecting cog-
nition, medical history assessment, and neuropsychological
testing. Subjects were asked to return for follow-up at a
two-year interval (average time between visits = 25.9 ± 7.9
months for MCI subjects; 24.3 ± 6.5 months for normal
control (NC)). From this potential pool of participants
we identified 45 subjects who had received a follow-up
neuropsychological assessment as of 2010 and who had good
quality MRI data at their initial visit. This resulted in a
subject pool of 25 MCI and 20 NC subjects. All subjects had
baseline MRI scans, while 20 MCI subjects and 19 control
subjects also had follow-up MRI exams. Five MCI subjects
converted to AD and 3 NC converted to MCI over the
timecourse of the study. Three of the MCI subjects who
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converted to AD were unable to complete a follow-up MRI
due to an inability to lie still inside the scanner, while two
additional MCI patients who did not convert and 1 NC who
converted to MCI refused an MRI at the time of follow-up.
All MRI scans were reviewed by a neuroradiologist to rule
out medical conditions that would preclude subjects from
participating in the study. Investigators were unaware of the
clinical data when deciding whether to exclude scans for poor
image quality. Demographic and clinical characteristics are
presented in Table 1. There were no significant differences
between MCI and NC groups for any of the characteristics
presented in Table 1. The study procedures were performed
at the Semel Institute for Neuroscience and Human Behavior
at the University of California, Los Angeles. Subjects gave
written informed consent according to the UCLA Human
Subjects Protection Committee procedures.
2.2. Neuropsychological Testing. All subjects were given the
Mini-Mental State Examination [30], the Hamilton Rating
Scale for Depression [31] to assess mood, and a clinical
interview at both initial and follow-up assessments. We
administered a battery of neuropsychological tests at both
visits [32] and divided scores into the following domains
of cognitive functioning: Processing Speed (Wechsler adult
intelligence scale-III Digit Symbol; Trailmaking test part
A; Stroop test, word reading speed), Executive Functioning
(Verbal fluency FAS and animal naming tests; Trailmaking
test part B; Stroop test, interference), and two memory
domains, based on subtests involved primarily in forming
new associations and those measured retrieval after a delay
period: Memory Encoding (Wechsler memory scale-III: Log-
ical Memory I and Verbal Paired Associates I; Buschke-Fuld
selective reminding test, consistent long-term retrieval), and
Delayed Memory (Rey Osterrieth Complex Figure, delayed
recall; Wechsler memory scale: Logical Memory II and Verbal
Paired Associates II; Buschke-Fuld selective reminding test,
delayed recall). To ascertain cognitive change in subjects, for
each of the cognitive measures, we first calculated change
scores (follow-up − baseline). These raw change scores
were converted to Z scores (Z = (raw score − mean)/
standard deviation)), and a domain Z score was obtained by
averaging those Z scores belonging to the cognitive tests in
that domain. In addition, an overall cognitive change Z score
was obtained by averaging the 5 domain Z scores. The overall
and domain Z scores were used to examine associations with
subregional cortical thickness [33, 34].
In order to diagnose MCI, we used recent standard
diagnostic criteria [35], which include (1) patient aware-
ness of memory decline, preferably confirmed by another
person; (2) greater-than normal cognitive impairment on
standardized tests; (3) normal daily activities performance;
and (4) no dementia. We included MCI subjects who
scored≥1 SD below age-corrected norms, as this impairment
threshold yields high sensitivity for predicting dementia
[36]. To balance increased sensitivity with specificity we
required impairment on at least two neuropsychological tests
per cognitive domain. We documented subjective memory
Table 1: Clinical and demographic characteristics of MCI (mild
cognitive impairment) and NC (normal control) subjects. Scores
are listed as mean (standard deviation).
Characteristic MCI NC
No. enrolled (baseline) 25 20
M/F 15/10 7/13
Age, y (baseline) 63.7 (10.7) 63.6 (11.9)
Education, y 17.1 (3.3) 16.6 (2.9)
Mini mental state examination 28.4 (1.4) 29.3 (0.9)
Hamilton depression scale score 2.04 (2.6) 1.45 (2.1)
Follow-up MRI completed 20 19
complaints using the Memory Functioning Questionnaire
[37] and clinical interview.
2.3. Neuroimaging. All MRI scans were performed on a
Siemens Allegra 3T head-only MRI scanner. We acquired
that sagittal T1-weighted magnetization prepared rapid
acquisition gradient-echo (MPRAGE) volumetric scans (TR
2300 ms, TE 2.93 ms, slice thickness 1 mm, 160 slices, inplane
voxel size 1.3 × 1.3 mm, FOV 256 mm) for volumetric mea-
surements and high-resolution oblique coronal T2-weighted
fast spin echo (FSE) sequences for structural segmentation
and unfolding procedures (TR 5200 ms, TE 105 ms, slice
thickness 3 mm, spacing 0 mm, 19 slices, in-plane voxel size
0.39× 0.39 mm, FOV 200 mm).
We used cortical unfolding to enhance the visibility of
the convoluted MTL cortex by flattening the entire MTL
gray matter volume to 2D-space [20, 21]. First we manually
defined white matter and cerebrospinal fluid (CSF) on the
oblique coronal T2 FSE structural MRI sequence with high
in-plane resolution. In order to maximize visibility of the
images for manual segmentation, high in-plane resolution
(0.39 × 0.39 mm) is critical. Our approach uses greater
slice thickness (3 mm) to increase signal to noise and tissue
contrast; to minimize the effect of this larger through-plane
resolution across slices on boundary changes, we acquired
images perpendicular to the long axis of the hippocampal
system where anatomical variability in hippocampal struc-
tures is smallest, thereby minimizing variability from slice to
slice while maximizing resolution in-plane where anatomic
variability is greatest. Once segmentation is complete, the
original images are interpolated by a factor of 7, resulting
in a final voxel size of 0.39 × 0.39 × 0.43 mm. Next, up
to 18 connected layers of gray matter are grown out from
the boundary of white matter, using a region-expansion
algorithm to cover all pixels defined as gray matter. This
produces a gray matter strip containing cornu ammonis
(CA) fields 1, 2, and 3, the dentate gyrus (DG), subiculum
(Sub), entorhinal cortex (ERC), perirhinal cortex (PRC),
parahippocampal cortex (PHC), and the fusiform gyrus
(FUS). We are unable to distinguish between CA fields 2,
3, and DG due to limits in resolution; thus we treat these
regions as a single entity (CA23DG). It is this strip of
gray matter that is the input for the unfolding procedure,
an iterative algorithm based on multidimensional scaling
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(http://airto.hosted.ats.ucla.edu/Hippocampus/) [19]. We
delineated boundaries between subregions on the original
in-plane MRI images, based on histological and MRI atlases
[38–40] and then projected them mathematically to their
corresponding coordinates in flat map space (Figure 1).
We calculated cortical thickness in all MTL subregions
(CA23DG, CA1, SUB, ERC, PRC, PHC, and FUS), averaged
over left and right hemispheres, as well as overall MTL
cortical thickness (Global) by averaging thickness across
these subregions. To calculate thickness, for each gray matter
voxel we computed the distance to the closest nongray matter
voxel. In 2D-space, for each voxel, we took the maximum
distance value of the corresponding 3D voxels across all layers
and multiplied by two. Mean thickness in each subregion was
calculated by averaging thickness of all 2D voxels within each
region of interest.
Manual segmentations were finalized and readied for
unfolding procedures by the same person. This investigator
was unaware of all demographic and clinical information.
All manual segmentations were performed in native space
in line with previous studies using the cortical unfolding
technique [17, 22, 23, 41]. We have previously reported
interrater and test-retest reliability analyses for the manual
procedures involved [17, 22, 41].
2.4. Statistical Analyses. The two sample t-test was used to
compare the continuous variables of cognitive groups, first
for total thickness averages across all subregions studied
within the MTL. Once significance was established for a
cognitive domain and total MTL thickness, t-tests were
then used to compare subregions within the MTL to that
particular cognitive domain, in order to determine the
subregions that contributed to the significant findings. Only
those domains found to have that significant associations
were further analyzed to determine region-specific associa-
tions. For significant associations, findings are presented as
Pearson correlation coefficients (r). Statistical analyses used
a significance level of P < .05 (two-tailed).
3. Results
Table 2 summarizes the neuropsychological test results from
NC and MCI subjects, while Table 3 summarizes the asso-
ciations between each of the four cognitive domains and
cortical thickness. Five of the MCI subjects converted to
AD within the 2-year interval between initial and follow-up
visits (20%). Three NC subjects converted to MCI over the
duration of the study. Within the MCI group, total averaged
thickness was correlated to averaged Z-change score in the
Memory Encoding Domain. Further investigation revealed
that lower cortical thickness in the ERC (r = 0.34; P = .003)
and Sub (r = 0.26; P = .011) at the subject’s initial visit
correlated to decline in averaged Z-scores in the Memory
Encoding Domain, but not the Delayed Memory Domain,
over the 2-year study interval (Figure 2). Results were similar
whether Rey-O scores were included or not. Additionally,
these findings were specific to the ERC and Sub regions;
no other subregions were significantly related to a decline
in Z-scores over time in either the Encoding or Delayed
Memory Domains at their follow-up assessment. These
analyses included subjects who converted to AD from the
MCI group, or to MCI from the NC group. When converters
in both groups were excluded, there were no significant
associations, demonstrating that the associations in the MCI
group were largely driven by converters. Total thickness
in the MTL was also significantly correlated to Z-change
score in the Processing Speed Domain, specifically that the
correlation was driven by an association between subicular
cortex and change over time in the Z-score Processing Speed
Domain. Also in MCI subjects, there were no significant
correlations between thickness in any subregions at their
initial assessment and change in scores in the Executive
Functioning Domain over time. NC did not demonstrate an
association between cortical thickness in any subregion at
initial assessment and change in performance over time in
any of the four cognitive domains (Figure 2). Additionally,
when all MCI and NC subjects were pooled together, there
were no significant associations between baseline cortical
thickness and change in cognitive scores in any of the four
domains.
Longitudinal assessment of structural change over time
revealed that MCI subjects, compared to NC subjects,
showed significantly greater cortical thinning in CA23DG,
CA1, Sub, and ERC and Total Thickness (averaged across
all the subregions). Subjects in the MCI group declined an
average of 2.3% in CA23DG, 3.4% in CA1, 4.6% in Sub, and
6.1% in ERC over the duration of the study (see Figure 3
for full results). Subjects in the normal group changed 0.9%
in CA23DG, 1.7% in CA1, 3.7% in Sub, and 4.8% in ERC.
When the 2/5 MCI subjects who converted to AD were
excluded (3 were unable to complete follow-up MRI), the
rate of change in ERC was 5.7% and 4.4% in Sub. When the
2/3 NC subjects who converted to MCI (1 refused follow-
up MRI) were excluded, ERC change dropped to 2.8% and
Sub change was 0.6%. Thinning over time was significantly
different for the two groups in averaged total hippocampus
(P = .007) and the following subregions: CA23DG (P =
5.0 × 10−4), CA1 (2.0 × 10−4), Sub (4.2 × 10−3), and ERC
(P = 8.2 × 10−3). Thinning over time was not, however
significantly correlated to cognitive change over time.
4. Discussion
The goal of the current study was to investigate whether
structural thinning in regions affected in the early stages of
AD pathology predicted decline over time on cognitive tests
known to involve these same brain regions. Our findings
show that reduced cortical thickness within the ERC and
Sub of MCI patients predicts decline over time on tests of
memory encoding but not delayed memory performance.
ERC is the gateway of cortical input to the hippocampus
[21, 25], enabling the binding of novel associations and shut-
tling bound information to neocortex [38]. The dissociation
of encoding and retrieval processes along the hippocampal
axis has been demonstrated by several studies [21, 42]
suggesting the involvement of anterior regions, such as ERC
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Table 2: Neuropsychological test performance: MCI and NC subjects scores on individual neuropsychological tests. Averages across specified
tests provide Domain scores. Both initial and follow-up raw scores, with standard deviation in parentheses, as well as average Z scores are
provided for both groups.
MCI subjects (N = 25) NC subjects (N = 20)
Initial visit
average raw
score
Follow-up
visit average
raw score
Z-scaled
change over
time
Initial visit
average raw
score
Follow-up
visit average
raw score
Z-scaled
change over
time
Domain Neuropsychological test
Processing
speed
Weschler adult intelligence scale-III
Digit Symbol
59.0 (14.5) 54.8 (16.0) −0.19 (1.1) 72.2 (14.6) 72.6 (19.7) 0.28 (0.8)
Trailmaking test part A∗∗ 36.0 (12.7) 36.7 (14.0) −0.01 (1.1) 29.3 (7.1) 30.5 (9.6) −0.01 (1.0)
Stroop test, word reading speed∗∗ 50.0 (8.7) 51.9 (8.4) −0.21 (1.0) 47.5 (5.9) 47.7 (8.5) 0.28 (1.0)
Average for Processing Speed Domain −0.14 0.18
Executive
functioning
Boston naming test letter fluency
(F.A.S)
39.6 (11.7) 35.6 (10.0) −0.39 (0.9) 40.0 (9.9) 45.6 (9.9) 0.46 (1.0)
Boston naming test category fluency
(Animal naming)
18.3 (4.03) 17.0 (4.8) −0.16 (1.0) 20.8 (4.0) 21.8 (4.5) 0.20 (1.0)
Trailmaking test part B∗∗ 92.9 (47.3) 103.8 (47.6) −0.13 (1.1) 63.6 (16.9) 72.3 (29.8) 0.14 (0.9)
Stroop test, Interference (Kaplan
version)∗∗
135.2 (30.4) 148.5 (42.1) −0.28 (1.0) 118.3 (31.1) 119.1 (34.7) 0.39 (0.9)
Average for Executive Functioning
Domain
−0.24 0.30
Memory
encoding
Weschler memory scale-III, logical
memory I
37.1 (11.9) 36.5 (11.4) −0.15 (1.2) 44.5 (8.2) 45.5 (10.5) 0.17 (0.6)
Weschler memory scale-III, verbal
paired associates I
16.8 (8.5) 16.8 (6.9) −0.19 (1.2) 23.7 (6.0) 24.4 (6.6) 0.24 (0.6)
Buschke-Fuld selective reminding test,
consistent long-term retrieval
48.3 (34.3) 36.2 (35.1) −0.35 (0.94) 57.3 (32.5) 63.4 (34.5) 0.39 (0.9)
Average for Memory Encoding
Domain
−0.23 0.27
Delayed
memory
Rey-Osterreith Complex Figure,
delayed recall
9.9 (4.6) 9.2 (6.0) −0.01 (1.0) 15.2 (5.7) 14.6 (6.7) 0.01 (1.0)
Weschler memory scale-III, logical
memory II
18.4 (9.8) 20.8 (10.7) 0.07 (1.1) 26.9 (7.8) 27.3 (8.3) −0.12 (0.8)
Weschler memory scale-III, verbal
paired associates II
5.1 (2.8) 5.7 (2.2) −0.01 (1.3) 7.2 (1.5) 7.3 (1.4) 0.04 (0.6)
Buschke-Fuld selective reminding test,
delayed recall
5.9 (3.7) 5.3 (4.2) −0.10 (1.0) 8.2 (2.4) 7.8 (3.4) 0.14 (1.0)
Average for Delayed Memory Domain 0.01 0.02
∗∗
Larger number indicates longer time to complete test, thus poorer performance. Z-score ± sign is inverted to represent this.
Table 3: Pearson Correlation Coefficients (r) and P-values for correlations between Cognitive Domains and Total Thickness averaged across
all subregions studied in the MTL as well as the subregions within the MTL that were significantly correlation to the Domain listed.
Cognitive domain Region of interest r P-value
Processing speed
Total thickness 0.38 .001
Subicular cortex 0.35 .002
Executive functioning Total thickness 0.07∗ .203∗
Memory encoding
Total thickness 0.17 .044
Entorhinal cortex 0.34 .003
Subicular cortex 0.26 .011
Delayed memory Total thickness 0.06∗ .253∗
∗
Not significant.
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CA 1
CA23DG
Fusiform
Subiculum
Parahippocampal
(a)
Fusiform
Perirhinal Entorhinal
CA1
CADG
CA23DG
Subiculum
Parahippocampal
(b)
Figure 1: Segmentation and Unfolding of Hippocampal Subregions. High-resolution images were segmented (a) defining gray matter within
the MTL. Boundary demarcations were drawn on the in-plane image and projected to flat map space (b) including CA fields 2, 3 and
the dentate gyrus (CA23DG), subiculum (Sub), entorhinal Cortex (ERC), perirhinal cortex (PRC), parahippocampal cortex (PHC), and
fusiform cortex (FUS).
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(a) Memory encoding domain correlated to entorhinal thickness in MCI
subjects
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(b) Delayed memory domain correlated to entorhinal thickness in MCI
subjects
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(c) Memory encoding domain correlated to subiculum thickness in MCI
subjects
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(d) Delayed memory domain correlated to subiculum thickness in MCI
subjects
Figure 2: Correlation of subregional thickness in MCI subjects at their initial visit to decline in averaged Z score performance within
cognitive domain over time. Scatterplots display: ERC thickness related to decline in Memory Encoding Domain (r = 0.34; P = .003, (a));
ERC thickness related to Z-change in Delayed Memory Domain ((b); not significant); Sub thickness related to decline in Memory Encoding
Domain (r = 0.26; P = .011, (c)); Sub thickness related to Z-change in Delayed Memory Domain ((d); not significant). MCI subjects who
converted to AD are highlighted in red on the Encoding Domain charts (a, c) to illustrate the relative thickness in ERC and Sub cortex
compared to subjects who did not convert.
in encoding and posterior regions in retrieval. AD pathology
begins primarily in the ERC, followed by immediate pro-
gression across projections through Sub to the hippocampus
proper [25]. The specificity of this pattern predicts specific
cognitive deficits related to disease-related regionally specific
neuronal death. This hypothesis is confirmed in the current
study, demonstrating that information in the initial encoding
stage is most susceptible to early AD-related pathology and
related to thinning in ERC and Sub.
In this study we separated out tests that measured the
initial memory-encoding episode from those that involved
delayed retrieval of information that had been learned
initially. These tests, which included the Buschke-Fuld selec-
tive reminding test consistent long-term retrieval section,
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Figure 3: Cortical thickness change over time (%) across subre-
gions. MCI subjects (N = 20) compared to normal control (N =
19) showed significantly greater cortical thinning in CA23DG, CA1,
Sub, and ERC and Total Thickness (CA23DG: CA fields 2, 3 and the
dentate gyrus, CA1: CA field 1, Sub: Subiculum, ERC: entorhinal
cortex, PRC: perirhinal cortex, PHC: parahippocampal cortex, Fus:
Fusiform gyrus).
immediate recall of word pairs, and immediate recall of a
prose passage, are challenging and require that subjects form
novel associations in the case of word paired learning, learn
novel information that exceeds immediate working memory
capacity, and consolidate that information dynamically over
multiple learning trials [43]. The formation of novel associa-
tions is considered a primary role of the hippocampus, and in
particular, the ERC. The delayed memory tests, which require
recalling information that had been encoded initially, are also
clearly related to memory encoding (since only information
encoded can be successfully recalled), however these scores
are also affected by additional processes such as initiating a
search for information, spontaneously retrieval information,
which may relate to frontal as well as hippocampal systems.
These measures were correlated in our study, however, only
decline in the encoding tests related to ERC thickness.
This suggests that measures of structural differences
in MTL subregions may predict change within cognitive
domains that involve these same brain regions. The speci-
ficity of this relationship suggests that subregional analysis
may be able to measure AD-specific pathology, though that
needs to be corroborated in studies with a more diverse MCI
(nonamnestic) and non-AD dementia populations. While
these measures are group averages of MCI patients compared
to normal subjects, they suggest that individual assessment
of structural changes within the MTL may identify those
subjects who are at greatest risk of longitudinal decline
in cognitive performance. Analysis of longitudinal change
rather than static measures of structural change may more
clearly differentiate subjects at the greatest risk of subsequent
decline, as we further refine the profile of individuals at the
greatest risk for progression into AD [18, 44, 45]. Of the 25
MCI subjects we followed longitudinally, five converted to
AD over the duration of the study; all five had lower-than-
average ERC and Sub thickness compared to the average for
MCI subjects.
Additionally three NC subjects converted to MCI over
the course of the study; all three had lower-than average
ERC and Sub thickness for the NC group average. This
supports previous studies that reduced cortical thickness in
MTL subregions predicts cognitive decline related to AD-
pathology [6, 11, 12]. However, it is noteworthy that some
subjects who did not convert to either AD from the MCI
pool or MCI from the NC pool also had lower than average
cortical thickness in ERC and Sub. Among the MCI group,
it is possible that these subjects have not yet converted to AD
but only future longitudinal studies will reveal the conversion
rates in these subjects. These findings suggest the importance
of continued longitudinal tracking of subjects at-risk for
AD. However, the small sample size of the current study
precludes definitive findings based on this sample. It is of
note that the rate of change in ERC thickness is nearly equal
for both the MCI group (4.1%) and the NC group (3.2%).
At follow-up testing, 3 of the 5 subjects who converted to
AD and 1 of the 3 NC who converted to MCI did not
complete follow-up MRI testing making it difficult to draw
conclusions on cortical thickness differences in convertes
compared to nonconverters in this particular sample. A
large portion of those MCI subjects most susceptible to
subsequent cognitive decline and conversion to AD did not
have follow-up MRI data available. However, when the two
NC subjects who converted to MCI were excluded from the
thickness calculations, the rate of decline in ERC dropped to
1.8%. Thus, the change in ERC thickness in NC over time
was mainly driven by those subjects who converted to MCI.
An intact MTL is necessary for the formation of episodic
memory [27] and among the earliest manifestations of AD
pathophysiology is a declining ability to form new memories,
even when patients are able to retrieve previously encoded
ones. While it is clear that the ability to encode new
memories is required for successful delayed retrieval of these
same items, we are arguing that there may be a dissociation of
these processes in early stages of the disease, perhaps related
to differential degradation of anterior MTL subregions
(entorhinal cortex) from posterior MTL subregions. While
the subiculum is present in both anterior and posterior
sections of the MTL, the ERC is clearly defined to anterior
MTL [25]. It is possible that the subiculum, or another
region, is more involved in the delayed memory effects of
AD and later chronological pathophysiological effects in the
course of the cascade of the disease. Thus, the pathophys-
iological AD-process that begins in the ERC [25] before
progressing to other MTL regions may be more significantly
affecting Memory Encoding than Delayed Memory. One
other possibility is that our delayed memory tests merely
tested a specific type of long-term memory and that further
tests will have to clarify the relationship between ERC and
memory subtypes. It is also possible that our sample size is
too small to detect subtle changes to Delayed Memory and
we suggest in the discussion that further studies with larger
sample sizes may aid in investigations of the correlation
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between AD-pathophysiology and neuropsychological test
performance.
In prior studies we argued that more subtle structural
MRI measures, such as the one used in the current study,
may reveal brain changes that are obscured in less sensitive
techniques and may account for previously mixed results on
the ability of the MTL to predict cognitive decline in AD [17].
Early structural changes in AD are limited to specific laminae
within neocortex, thus measures of thickness may be more
sensitive than whole-region volumetric assessments, blurring
regionally specific changes with regions that have yet to
experience neuronal degeneration due to disease pathology.
By focusing structural analyses on regions known to be first
affected in AD we may better identify those individuals at
greatest risk for future memory decline.
There are several potential limitations of the present
study including a relatively small N and the time consuming
nature of this study, which makes it difficult to generalize to
clinical practice. However, as we continue to develop these
techniques and identify optimal predictive variables, we may
be able to automate those procedures most likely to show
changes over time. Additionally there are limitations to the
use of cognitive domains as measures of isolated cognitive
impairment. Delayed recall is clearly impaired in patients
with hippocampal damage, but the presumption is that this
is due to a failure for information to fully consolidate during
the initial encoding episode. These results provide support
for the notion that the ERC is particularly important for
this initial episodic encoding. No cognitive domains can be
tested in isolation, and by necessity executive functions are
important in both encoding and retrieval; similarly initial
encoding tests are correlated with delayed recall, as the latter
is dependent on the former; thus these processes can never
be entirely isolated. However by looking across a range of
tests with some similar characteristics, the domain approach
tends to remove variability due to specific aspects of a single
test and will better emphasize underlying, shared cognitive
processes. This method also offers the advantage of reducing
the number of comparisons, which can lead to spurious
results.
Our results demonstrate a relationship in MCI patients
between cortical thinning in ERC and Sub and decline in
the ability to encode new memories over time. Given the
involvement of the ERC and surrounding neocortices in the
early stages of neurodegeneration in AD, clarifying the roles
of these brain regions in associative memory is a critical goal
in understanding the link between disease pathophysiology
and resultant cognitive decline.
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